4DN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Denali Therapeutics Inc

Watchlist Manager

Watchlist

Price: 21.31 EUR 1.33% Market Closed

Market Cap: €5.9B

D	Denali Therapeutics Inc SWB:4DN	US
U	United Bank Ltd KAR:UBL	PK
W	Waratah Minerals Ltd OTC:BTRYF	AU
C	Celsius Resources Ltd F:FX8	AU
	Spartoo SAS SA PAR:ALSPT	FR
	Viva Leisure Ltd ASX:VVA	AU
O	Onward Technologies Ltd BSE:517536	IN

Profitability Summary

Denali Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

97%

Sustainable 3Y Average Gross Margin

24%

Negative Operating Margin

-15.058%

Negative 3Y Average Operating Margin

-13.328%

Declining Operating Margin

-50% > -15.058%

Negative Net Margin

-14.191%

Negative 3Y Average Net Margin

-11.641%

Declining Net Margin

-37% > -14.191%

Negative Free Cash Flow Margin

-12.937%

Negative 3Y Average Free Cash Flow Margin

-11.034%

Declining Free Cash Flow Margin

-102% > -12.937%

Negative ROE

-55%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-134%

Declining ROIC

-140% > -157%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.